English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/206782
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients

AuthorsTenorio, Jair; Alarcón, Pablo; Arias, Pedro; Dapía, Irene; García-Miñaur, Sixto; Palomares, María; Campistol, Jaume; Climent, Salvado; Valenzuela, Irene; Ramos, Sergio ; Martínez Monseny, Antonio; López Grondona, Fermina; Botet, Javier ; Serrano, Mercedes; Solís, Mario; Santos-Simarro, Fernando; Álvarez, Sara; Teixidó-Tura, Gisela; Fernández Jaén, Alberto; Gordo, Gema; Bardón Rivera, María Belén; Nevado, Julian; Hernández, Alicia; Cigudosa, Juan C.; Ruiz-Pérez, Victor L. ; Tizzano, Eduardo F.; Lapunzina, Pablo
KeywordsGenetics research
Medical genetics
Issue Date2019
PublisherSpringer Nature
CitationEuropean Journal of Human Genetics 28: 469–479 (2019)
AbstractTatton-Brown-Rahman (TBRS) syndrome is a recently described overgrowth syndrome caused by loss of function variants in the DNMT3A gene. This gene encodes for a DNA methyltransferase 3 alpha, which is involved in epigenetic regulation, especially during embryonic development. Somatic variants in DNMT3A have been widely studied in different types of tumors, including acute myeloid leukemia, hematopoietic, and lymphoid cancers. Germline gain-of-function variants in this gene have been recently implicated in microcephalic dwarfism. Common clinical features of patients with TBRS include tall stature, macrocephaly, intellectual disability (ID), and a distinctive facial appearance. Differential diagnosis of TBRS comprises Sotos, Weaver, and Malan Syndromes. The majority of these disorders present other clinical features with a high clinical overlap, making necessary a molecular confirmation of the clinical diagnosis. We here describe seven new patients with variants in DNMT3A, four of them with neuropsychiatric disorders, including schizophrenia and psychotic behavior. In addition, one of the patients has developed a brain tumor in adulthood. This patient has also cerebral atrophy, aggressive behavior, ID, and abnormal facial features. Clinical evaluation of this group of patients should include a complete neuropsychiatric assessment together with psychological support in order to detect and manage abnormal behaviors such as aggressiveness, impulsivity, and attention deficit-hyperactivity disorder. TBRS should be suspected in patients with overgrowth, ID, tall stature, and macrocephaly, who also have some neuropsychiatric disorders without any genetic defects in the commonest overgrowth disorders. Molecular confirmation in these patients is mandatory.
Publisher version (URL)http://dx.doi.org/10.1038/s41431-019-0485-3
URIhttp://hdl.handle.net/10261/206782
DOI10.1038/s41431-019-0485-3
ISSN1018-4813
E-ISSN1476-5438
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.